JPS6416728A - Aqueous preparation - Google Patents
Aqueous preparationInfo
- Publication number
- JPS6416728A JPS6416728A JP62170209A JP17020987A JPS6416728A JP S6416728 A JPS6416728 A JP S6416728A JP 62170209 A JP62170209 A JP 62170209A JP 17020987 A JP17020987 A JP 17020987A JP S6416728 A JPS6416728 A JP S6416728A
- Authority
- JP
- Japan
- Prior art keywords
- aqueous preparation
- cyclodextrin
- drug
- active agent
- chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
PURPOSE:To obtain an aqueous preparation such as clear eye drops not becoming cloudy, containing a drug such as sodium hyaluronate, a cationic surface active agent such as benzalkonium chloride and cyclodextrin or a derivative thereof. CONSTITUTION:An aqueous preparation containing a drug (e.g. sodium hyaluronate, lysozyme chloride or sodium chondroitin sulfate), a cationic surface active agent (e.g. benzalkonium chloride or chlorohexidine chloride) as an antiseptic and cyclodextrin or a derivative thereof. The aqueous preparation causes neither cloudy material nor precipitation by addition of cyclodextrin, etc., even in blending of the cationic active agent as an antiseptic and a drug wherein the blending has been forbidden.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62170209A JPS6416728A (en) | 1987-07-07 | 1987-07-07 | Aqueous preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62170209A JPS6416728A (en) | 1987-07-07 | 1987-07-07 | Aqueous preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6416728A true JPS6416728A (en) | 1989-01-20 |
Family
ID=15900690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62170209A Pending JPS6416728A (en) | 1987-07-07 | 1987-07-07 | Aqueous preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6416728A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996022088A1 (en) * | 1995-01-20 | 1996-07-25 | Wakamoto Pharmaceutical Co., Ltd. | Anti-inflammatory eyedrops |
JP2000143501A (en) * | 1998-11-12 | 2000-05-23 | Zeria Pharmaceut Co Ltd | Sulfa drug-containing ophthalmic solution |
CN1087169C (en) * | 1995-01-20 | 2002-07-10 | 若素制药株式会社 | Anti-inflammatory eyecrops |
WO2002032459A3 (en) * | 2000-10-17 | 2002-08-15 | Massachusetts Inst Technology | Method of increasing the efficacy of antibiotics by complexing with cyclodextrins |
JP2005247801A (en) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | Stable eye drops |
JP2005247795A (en) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | Stable eye drops |
JP2005529879A (en) * | 2002-04-19 | 2005-10-06 | ノバルティス アクチエンゲゼルシャフト | New biomaterials, their manufacture and use |
WO2008146104A3 (en) * | 2007-06-01 | 2009-11-12 | Hertek Sa | Stable liquid composition of chondroitinsulfate and glucosamine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5746922A (en) * | 1980-09-05 | 1982-03-17 | Ss Pharmaceut Co Ltd | Stable aqueous lysozyme solution |
JPS62190121A (en) * | 1986-02-17 | 1987-08-20 | Senjiyu Seiyaku Kk | Water-based liquid agent |
-
1987
- 1987-07-07 JP JP62170209A patent/JPS6416728A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5746922A (en) * | 1980-09-05 | 1982-03-17 | Ss Pharmaceut Co Ltd | Stable aqueous lysozyme solution |
JPS62190121A (en) * | 1986-02-17 | 1987-08-20 | Senjiyu Seiyaku Kk | Water-based liquid agent |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996022088A1 (en) * | 1995-01-20 | 1996-07-25 | Wakamoto Pharmaceutical Co., Ltd. | Anti-inflammatory eyedrops |
CN1087169C (en) * | 1995-01-20 | 2002-07-10 | 若素制药株式会社 | Anti-inflammatory eyecrops |
JP2000143501A (en) * | 1998-11-12 | 2000-05-23 | Zeria Pharmaceut Co Ltd | Sulfa drug-containing ophthalmic solution |
WO2002032459A3 (en) * | 2000-10-17 | 2002-08-15 | Massachusetts Inst Technology | Method of increasing the efficacy of antibiotics by complexing with cyclodextrins |
JP2005529879A (en) * | 2002-04-19 | 2005-10-06 | ノバルティス アクチエンゲゼルシャフト | New biomaterials, their manufacture and use |
JP2005247801A (en) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | Stable eye drops |
JP2005247795A (en) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | Stable eye drops |
WO2008146104A3 (en) * | 2007-06-01 | 2009-11-12 | Hertek Sa | Stable liquid composition of chondroitinsulfate and glucosamine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTIP1418A (en) | Hyaluronic acid associates, composition containing them, process for preparing the composition, process for preparing zinc hyaluronate aqueous solution | |
CA2126083A1 (en) | Use of app modulators for the manufacture of a medicament for the treatment of amyloidosis | |
CA2278802A1 (en) | Ophthalmic compositions including glycerin and propylene glycol | |
AU567257B2 (en) | Sucralfat-suspension | |
MXPA98003802A (en) | Stabilized thyroid hormone preparations and methods of making same. | |
AU2152688A (en) | Dosage form comprising fast agent delivery followed by slow agent delivery | |
FR2596393B1 (en) | HYDROXY-3 DIHYDROXYOXOPHOSPHORIO-4 BUTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM | |
HUT52030A (en) | Fungicide, insecticide and miticide compositions containing propene-carboxylic acid derivatives as active components and process for producing the active components | |
ZA916770B (en) | Nonaqueous fluorinated drug delivery vehicle suspensions | |
EP0214647A3 (en) | Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes | |
HUT61196A (en) | Process for producing pharmaceutical composition which may be dropped in the eye | |
AU6231790A (en) | Active sizing compositions | |
HUT55403A (en) | Process for producing modified gangliosides and their functional derivatives, as well as pharmaceutical compositions comprising such active ingredient | |
GR3023541T3 (en) | N,O-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them | |
AU3091489A (en) | Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient | |
CA2010786A1 (en) | Surfactant combination | |
CA2226548A1 (en) | Lyophilized hepatocyte growth factor preparations | |
HK1019005A1 (en) | Synthetic viscoelastic material for physiological applications such as for ophthalmic applications | |
JPS6416728A (en) | Aqueous preparation | |
AU1464388A (en) | Pharmaceutical compositions in the form of stable sucralfate suspensions free of suspending agents | |
HUT43828A (en) | Process for producing 1,1-disubstituted cyclopropan derivatives and pharmaceutical and/or fungicide compositions containing them as active agents | |
AU3873789A (en) | Stable, active chlorine-containing anti-microbial compositions | |
IE40957B1 (en) | A 4-0- ,d glucopyransyl-2-deoxystreptamine, a process for its preparing, and compositions incorporating it | |
EP0475383A3 (en) | Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient | |
MY108877A (en) | Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives. |